Our vision is to make pharma marketing effective and efficient
Express Pharma|December 2020
Doceree, a physician-only platform for programmatic marketing, is working towards building more effective ways for pharma brands to keep the doctors community engaged. Dr Harshit Jain, Founder and CEO, Doceree, outlines why it is important for pharma brands to redraw their doctor engagement strategies with the help of digital tools to reduce marketing costs, improve outcomes and ensure regulatory compliance, in an interview with Usha Sharma
Usha Sharma
Our vision is to make pharma marketing effective and efficient

Give us a brief understanding of Doceree? What is its USP?

Doceree is the global physician-only platforms for programmatic marketing. Our platform is disrupting the physician marketing landscape much in the same way digital ad networks transformed the consumer marketing space. Doceree’s integrated and collaborative ecosystem enables pharmaceutical brands and digital platforms to mutually benefit from the untapped opportunities present in physician marketing in the most ‘regulatory compliant and transparent manner’.

Doceree is enabling Rx drug marketers to promote their brands in the digital domain to physicians in a regulated manner. At the same time, Doceree provides an opportunity for digital platforms to make more revenue. With our platform, they can now focus on their core business and the problems they are solving in healthcare than swaying their attention to making more monies. Effectiveness and efficiency are our prime differentiators that come from our razor-sharp focus on doctor-only platforms. Unlike other companies in the US where we have competition in programmatic physician marketing space, Doceree is focussing on doctor-only platforms for pharma brands to market themselves.

Besides this, we are the only company in the category that has a global footprint with offices in the US and India. In India, we are the only programmatic platform in physician marketing. The underlying thought is to ensure effectiveness. Our proprietary identity resolution tool - Espyian helps precision target physicians, bringing in efficiency to physician marketing.

This story is from the December 2020 edition of Express Pharma.

Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 8,500+ magazines and newspapers.

This story is from the December 2020 edition of Express Pharma.

Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 8,500+ magazines and newspapers.

MORE STORIES FROM EXPRESS PHARMAView All
Achieving Aatmanirbharta In APIs Are We On The Right Track?
Express Pharma

Achieving Aatmanirbharta In APIs Are We On The Right Track?

As India gears up to celebrate its 75th Independence Day, self reliance in APIs remains a key goal for the pharma sector. AatmaNirbharta will be crucial for the sector as it continues to protect the country from the existing and emerging health threats

time-read
9 mins  |
August 2021
Yokogawa launches OpreX Data Model Broker
Express Pharma

Yokogawa launches OpreX Data Model Broker

A plant data transformation platform, OpreX automatically verifies discrepancies and inconsistencies in data to improve efficiency in plant construction and operation

time-read
2 mins  |
August 2021
Understanding the nuances of generics injectables
Express Pharma

Understanding the nuances of generics injectables

At a webinar, explaining the West Pharma's AccelTRA Components Program, industry experts explained why the use of glass vials and stoppers as primary container closure systems (CCS) has become crucial

time-read
6 mins  |
August 2021
Trending in nutraceuticals: Science meets sustainability
Express Pharma

Trending in nutraceuticals: Science meets sustainability

Zeljko Pockaj, Vice President, Global Pharmaceutical Industry, mentions the key trends that are believed to drive innovations and formulations for nutraceuticals’ development around the globe

time-read
3 mins  |
August 2021
The growth of e-pharmacies in India
Express Pharma

The growth of e-pharmacies in India

Rahul Nath Choudhury, Research fellow, ICWA, explains what motivates people in the pharma industry to invest into e-pharmacies, along with various other growth factors associated with these

time-read
4 mins  |
August 2021
Xylitol and Maltitol: Low-calorie sugar alternatives
Express Pharma

Xylitol and Maltitol: Low-calorie sugar alternatives

Polyols like Xylitol and Maltitol offer important health benefits. Unlike general sugar-free sweeteners, these do not have any bitter-after taste

time-read
4 mins  |
August 2021
Single-use TC gaskets and their importance
Express Pharma

Single-use TC gaskets and their importance

Depending on the application, gaskets are manufactured by different types of Material of Construction (MOC) such as Silicone, EPDM, Viton (FKM), Nitrile, Neoprene, PTFE, etc.

time-read
2 mins  |
August 2021
It's important to enhance customer experience so that existing customers are more loyal
Express Pharma

It's important to enhance customer experience so that existing customers are more loyal

Sheshgiri Kamath, CEO and co-founder, Kapture CRM, expands on why it is important for pharma companies to enhance customer experience, and how the right CRM solution can help companies to identify, address and manage customer expectations more effectively, in an interaction with Viveka Roychowdhury

time-read
5 mins  |
August 2021
From HIV to COVID-19: The role of liposomal nanotechnology as an NDDS of choice
Express Pharma

From HIV to COVID-19: The role of liposomal nanotechnology as an NDDS of choice

Arun Kedia, Managing Director,VAV Life Sciences, elaborates how NDDS have proved to be beneficial with applications across various medical therapies ranging from HIV to cancer to COVID-19 treatment

time-read
4 mins  |
August 2021
Ensuring pharma compliance with testo data loggers
Express Pharma

Ensuring pharma compliance with testo data loggers

Testo data loggers can be used to test the optimum conditions for specific products or surroundings

time-read
2 mins  |
August 2021